Immune checkpoint blockades in gynecological cancers: A review of clinical trials

Advanced and recurrent gynecological cancers are associated with a poor prognosis and there is still a lack of effective treatments. Immune checkpoint blockade (ICB) therapy is an important element of cancer‐targeted therapy and immunotherapy. The programed cell death protein 1 (PD‐1) and cytotoxic...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Acta obstetricia et gynecologica Scandinavica 2022-09, Vol.101 (9), p.941-951
Hauptverfasser:	Peng, Hongling, He, Xiang, Wang, Qiao
Format:	Artikel
Sprache:	eng
Schlagworte:	Cancer therapies Cervical cancer Clinical trials Endometrial cancer Gynecological cancer Gynecology immune checkpoint blockades Immunotherapy Medical prognosis Monoclonal antibodies Ovarian cancer Review Targeted cancer therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!